Sumitomo Mitsui Trust Holdings, Inc. Alkermes Plc. Put Options Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$831 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$571 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$410 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$314 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$263 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.69B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...